Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.379ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.379EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.379EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.379ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.379ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.240EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.240EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.240ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.240ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.240EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.240EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.240ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.240ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.240.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.240.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.240.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.240.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.240.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.240.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.240.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.240.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.121.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
AY.121.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-2445.63South Korea
AY.121.1 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
AY.121.1 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
AY.121.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
AY.121.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
AY.121.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
AY.121.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.46EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.46ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.46ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.46EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.46EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AZ.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AZ.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AZ.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AZ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.270EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.270EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.270ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.270ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.270EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.270EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.270ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used